Exceptions occur when skin leads to repeated infections, severe rashes, or loss of function
Zero adverse events (Kuceki et al., 2025)
Slo pueden ofrecerse bajo directrices federales especficas y la FDA no revisa su seguridad, eficacia o calidad de fabricacin
Following these storage tips avoids waste, keeps it safe, and ensures consistent treatment outcomes
Given the significant differences in mechanism, evidence, regulatory status, and clinical indication, a direct head-to-head comparison of retatrutide and tesamorelin as interchangeable options is not clinically appropriate
We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation